Innovation
5 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant.
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Glycoprotein IIb/IIIa inhibitors fro the treatment of cardiovascular diseases.
5 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant.
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |